Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients.

por Ioannis Boukovinas, Chara Papadaki, Pedro Mendez, Miquel Taron, Dimitris Mavroudis, Anastasios Koutsopoulos, Maria Sanchez-Ronco, Jose Javier Sanchez, Maria Trypaki, Eustathios Staphopoulos, Vassilis Georgoulias, Rafael Rosell, John Souglakos
Publicado 2008